MedPath

Fluocinonide

Generic Name
Fluocinonide
Brand Names
Lidemol, Lidex, Lyderm, Tiamol, Vanos
Drug Type
Small Molecule
Chemical Formula
C26H32F2O7
CAS Number
356-12-7
Unique Ingredient Identifier
2W4A77YPAN
Background

A topical glucocorticoid used in the treatment of eczema.

Indication

A topical anti-inflammatory product for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Associated Conditions
Dermatosis, Inflammation, Pruritus
Clinical Trials
Related News

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

Phase 1
Recruiting
Conditions
Atopic Dermatitis
Interventions
Drug: ShA9 Topical Gel
Drug: Placebo (Vehicle) Topical Gel
First Posted Date
2024-07-16
Last Posted Date
2025-05-11
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
86
Registration Number
NCT06504160
Locations
🇺🇸

University of California, San Diego: Dermatology Clinical Trials Unit, San Diego, California, United States

🇺🇸

National Jewish Health: Division of Pediatric Allergy and Clinical Immunology, Denver, Colorado, United States

🇺🇸

Northwestern University Feinberg School of Medicine: Department of Dermatology, Chicago, Illinois, United States

and more 5 locations

Impact of Fluocinonide 0,05% in Oral Lichen Planus

Not Applicable
Recruiting
Conditions
Oral Lichen Planus
Interventions
Drug: Placebo
First Posted Date
2023-11-18
Last Posted Date
2023-11-18
Lead Sponsor
University of Catania
Target Recruit Count
20
Registration Number
NCT06135805
Locations
🇮🇹

AOU Policlinico G. Rodolico, Catania, Italy

Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma

Not Applicable
Withdrawn
Conditions
Mycosis Fungoides
Interventions
First Posted Date
2014-11-26
Last Posted Date
2021-04-27
Lead Sponsor
Rochester General Hospital
Registration Number
NCT02301494

Cutaneous Lupus Medication Experience Study

Completed
Conditions
Cutaneous Lupus
Interventions
First Posted Date
2014-06-26
Last Posted Date
2025-04-24
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
11
Registration Number
NCT02176148
Locations
🇺🇸

Wake Forest University School of Medicine - Department of Dermatology, Winston-Salem, North Carolina, United States

Using an Internet Study to Improve Adherence for Psoriasis Patients

Early Phase 1
Completed
Conditions
Psoriasis
Interventions
Behavioral: Internet Survey
First Posted Date
2013-03-01
Last Posted Date
2020-06-04
Lead Sponsor
Wake Forest University
Target Recruit Count
40
Registration Number
NCT01802580
Locations
🇺🇸

Wake Forest University Health Sciences Department of Dermatology, Winston-Salem, North Carolina, United States

Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis

Phase 2
Completed
Conditions
Atopic Dermatitis
Interventions
First Posted Date
2011-11-10
Last Posted Date
2018-09-07
Lead Sponsor
Wake Forest University
Target Recruit Count
10
Registration Number
NCT01469767
Locations
🇺🇸

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy

Phase 2
Completed
Conditions
Breast Carcinoma
Interventions
Procedure: Management of Therapy Complications
Other: Questionnaire Administration
First Posted Date
2011-08-24
Last Posted Date
2017-08-09
Lead Sponsor
OHSU Knight Cancer Institute
Target Recruit Count
34
Registration Number
NCT01422408
Locations
🇺🇸

OHSU Knight Cancer Institute, Portland, Oregon, United States

A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitis

Phase 4
Completed
Conditions
Atopic Dermatitis
Interventions
First Posted Date
2010-01-14
Last Posted Date
2018-08-01
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
20
Registration Number
NCT01049243
Locations
🇺🇸

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

VANOS Cream and Skin Barrier Function

Phase 4
Completed
Conditions
Atopic Dermatitis
Interventions
First Posted Date
2009-01-09
Last Posted Date
2017-07-11
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
25
Registration Number
NCT00819507
Locations
🇺🇸

Oregon Health & Science University Department of Dermatology, Portland, Oregon, United States

Sorafenib-induced Hand- Foot Skin Reaction Treatment

Phase 2
Terminated
Conditions
Hand-foot Skin Reaction
Rash
Interventions
Drug: bland emollient cream (Udderly smooth® Udder Cream)
First Posted Date
2008-04-28
Last Posted Date
2013-06-05
Lead Sponsor
Northwestern University
Target Recruit Count
6
Registration Number
NCT00667589
Locations
🇺🇸

Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy